Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect of a Change in Accounting Principle	Common Stock	Treasury Stock	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect of a Change in Accounting Principle	Retained Earnings	Retained Earnings Cumulative Effect of a Change in Accounting Principle	Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (in shares) at Dec. 31, 2021			54,073
Balance at beginning of period at Dec. 31, 2021	$ 1,146,689	$ (56,233)	$ 54	$ (238,109)	$ 1,024,580	$ (72,742)	$ 368,571	$ 16,509	$ (8,407)
Balance at beginning of period (in shares) at Dec. 31, 2021				(9,894)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	5,648						5,648
Other comprehensive income (loss)	(8,680)								(8,680)
Stock repurchases (in shares)				(389)
Stock repurchases	(52,210)			$ (52,210)
Share-based compensation	68,247				68,247
Issuance of common stock under employee stock plans (in shares)			957
Issuance of common stock under employee stock plans	40,182		$ 1		40,181
Tax payments related to restricted stock units	(13,506)				(13,506)
Balance at end of period (in shares) at Dec. 31, 2022			55,030
Balance at end of period at Dec. 31, 2022	1,130,137		$ 55	$ (290,319)	1,046,760		390,728		(17,087)
Balance at end of period (in shares) at Dec. 31, 2022				(10,283)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(20,371)						(20,371)
Other comprehensive income (loss)	3,655								3,655
Share-based compensation	59,683				59,683
Issuance of common stock under employee stock plans (in shares)			792
Issuance of common stock under employee stock plans	23,216		$ 1		23,215
Tax payments related to restricted stock units	$ (7,366)				(7,366)
Balance at end of period (in shares) at Dec. 31, 2023	45,539		55,822
Balance at end of period at Dec. 31, 2023	$ 1,188,954		$ 56	$ (290,319)	1,122,292		370,357		(13,432)
Balance at end of period (in shares) at Dec. 31, 2023	(10,283)			(10,283)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ 12,531						12,531
Other comprehensive income (loss)	(3,763)								(3,763)
Share-based compensation	42,912				42,912
Issuance of common stock under employee stock plans (in shares)			843
Issuance of common stock under employee stock plans	13,411		$ 1		13,410
Tax payments related to restricted stock units	(4,827)				(4,827)
Purchase of convertible note hedge	(40,279)				(40,279)
Sale of warrants	25,168				25,168
Tax benefit related to convertible note hedge	10,225				10,225
Partial unwind of convertible note hedge and warrants	$ (1,019)				(1,019)
Balance at end of period (in shares) at Dec. 31, 2024	46,382		56,665
Balance at end of period at Dec. 31, 2024	$ 1,243,313		$ 57	$ (290,319)	$ 1,167,882		$ 382,888		$ (17,195)
Balance at end of period (in shares) at Dec. 31, 2024	(10,283)			(10,283)